AUM Biosciences announces closing of USD $27Million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

Aum Biosciences Announces Closing Of Usd $27million In A "series A" Round Of Funding To Advance Its Clinical Stage Pipeline Of Precision And Targeted Cancer Therapies

Facebook Comments

Leave a Reply

CommentLuv badge